Andrew Miller
- Psychiatry and Mental health top 5%
- Molecular Biology
- Cellular and Molecular Neuroscience top 10%
- Pharmacology top 10%
- Biological Psychiatry top 5%
- Co-authors
- Stephen K. BrannanAlan BreierSharon SawchakSteven M. PaulJeffrey A. LiebermanInder KaulChristoph U. CorrellHaiyuan Zhu
- Topics
- Schizophrenia research and treatment (8 papers)Receptor Mechanisms and Signaling (6 papers)Ion channel regulation and function (3 papers)
- Journals
- New England Journal of MedicineThe LancetSHILAP Revista de lepidopterología
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Andrew Miller
19 papers receiving 730 citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Psychiatry and Mental health 393
- Molecular Biology 296
- Cellular and Molecular Neuroscience 221
- Pharmacology 121
- Biological Psychiatry 118
Countries citing papers authored by Andrew Miller
This map shows the geographic impact of Andrew Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Miller more than expected).
Fields of papers citing papers by Andrew Miller
This network shows the impact of papers produced by Andrew Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Miller. The network helps show where Andrew Miller may publish in the future.
Co-authorship network of co-authors of Andrew Miller
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Miller. A scholar is included among the top collaborators of Andrew Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Miller. Andrew Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 13 | |
| 3 | 1 | |
| 4 | 26 | |
| 5 | Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophreniabreakdown → | 71 |
| 6 | 40 | |
| 7 | Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trialbreakdown → | 104 |
| 8 | 65 | |
| 9 | 45 | |
| 10 | 84 | |
| 11 | Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophreniabreakdown → | 216 |
| 12 | 4 | |
| 13 | 11 | |
| 14 | 24 | |
| 15 | 5 | |
| 16 | 20 | |
| 17 | 5 | |
| 18 | 4 | |
| 19 | 8 |
About Andrew Miller
Andrew Miller is a scholar working on Biological Psychiatry, Psychiatry and Mental health and Cellular and Molecular Neuroscience, having authored 19 papers that have together received 747 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (8 papers), Receptor Mechanisms and Signaling (6 papers) and Ion channel regulation and function (3 papers). The work is most often cited by research in Biological Psychiatry (118 citations), Psychiatry and Mental health (393 citations) and Cellular and Molecular Neuroscience (221 citations). Andrew Miller has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Stephen K. Brannan, Alan Breier, Sharon Sawchak, Steven M. Paul, Jeffrey A. Lieberman, Inder Kaul, Steven M. Paul, Christoph U. Correll, Haiyuan Zhu and Samantha E. Yohn. Their work appears in journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.